
NHI Stock Forecast & Price Target
NHI Analyst Ratings
Bulls say
National Health Investors Inc. has shown a positive outlook, with an increase in normalized funds from operations (NFFO) estimates for both 2025 and 2026, reflecting strong earnings performance and management's encouraging guidance. The 2025 normalized FFO estimate is projected to rise to $4.80 per share, which aligns with management's revised guidance, and indicates an expected growth of 5.3% year-over-year. Furthermore, the projected 2026 FFO estimate of $5.03 per share slightly exceeds consensus expectations, suggesting continued financial momentum.
Bears say
National Health Investors Inc. exhibits a negative outlook primarily due to the anticipated lower earnings growth over the coming years, influenced by challenges related to operator transitions and potential underperformance during rent resets, particularly regarding key tenants. Additionally, the risk of weaker deferred rent collections further compounds this outlook, as the company could be adversely affected if operators face difficulties, especially in light of possible future pandemic-related disruptions. This combination of operational challenges and revenue uncertainties leads to caution concerning the company’s financial stability and long-term growth prospects.
This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.
NHI Analyst Forecast & Price Prediction
Start investing in NHI
Order type
Buy in
Order amount
Est. shares
0 shares